Mind Medicine Inc (NASDAQ: MNMD) is 24.97% higher on its value in year-to-date trading and has touched a low of $4.70 and a high of $10.44 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The MNMD stock was last observed hovering at around $9.64 in the last trading session, with the day’s gains setting it 0.27%.
Currently trading at $9.91, the stock is 25.17% and 32.78% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.04 million and changing 2.80% at the moment leaves the stock 41.74% off its SMA200. MNMD registered 42.39% gain for a year compared to 6-month loss of 38.02%. The firm has a 50-day simple moving average (SMA 50) of $7.4636 and a 200-day simple moving average (SMA200) of $6.99155.
The stock witnessed a 49.13% gain in the last 1 month and extending the period to 3 months gives it a 70.86%, and is 15.50% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.02% over the week and 5.90% over the month.
Mind Medicine Inc (MNMD) has around 74 employees, a market worth around $748.73M and $0.00M in sales. Distance from 52-week low is 110.85% and -5.04% from its 52-week high. The company has generated returns on investments over the last 12 months (-31.70%).
The EPS is expected to grow by 6.73% this year
248.0 institutions hold shares in Mind Medicine Inc (MNMD), with institutional investors hold 55.61% of the company’s shares. The shares outstanding are 75.51M, and float is at 72.87M with Short Float at 15.32%. Institutions hold 55.14% of the Float.
The top institutional shareholder in the company is COMMODORE CAPITAL LP with over 7.15 million shares valued at $51.52 million. The investor’s holdings represent 9.9369 of the MNMD Shares outstanding. As of 2024-06-30, the second largest holder is DEEP TRACK CAPITAL, LP with 6.1 million shares valued at $44.01 million to account for 8.4879 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 5.38 million shares representing 7.4869 and valued at over $38.82 million, while DRIEHAUS CAPITAL MANAGEMENT LLC holds 3.5299 of the shares totaling 2.54 million with a market value of $18.3 million.
Mind Medicine Inc (MNMD) Insider Activity
The most recent transaction is an insider sale by Sullivan Mark, the company’s Chief Legal Officer. SEC filings show that Sullivan Mark sold 11,491 shares of the company’s common stock on Jun 25 ’25 at a price of $6.80 per share for a total of $78139.0. Following the sale, the insider now owns 0.31 million shares.
Mind Medicine Inc disclosed in a document filed with the SEC on Jun 25 ’25 that Karlin Daniel (Chief Medical Officer) sold a total of 7,848 shares of the company’s common stock. The trade occurred on Jun 25 ’25 and was made at $6.80 per share for $53366.0. Following the transaction, the insider now directly holds 0.44 million shares of the MNMD stock.
Still, SEC filings show that on Jun 25 ’25, Barrow Robert (Chief Executive Officer) disposed off 26,491 shares at an average price of $6.80 for $0.18 million. The insider now directly holds 830,065 shares of Mind Medicine Inc (MNMD).
